Innocan Pharma Corp. buy Maxi_Scalibusa
Start price
23.01.21
/
50%
€0.31
Target price
23.01.22
€6.00
Performance (%)
33.11%
End price
24.01.22
€0.41
Summary
This prediction ended on 24.01.22 with a price of €0.41. With a performance of 33.11% the BUY prediction by Maxi_Scalibusa was a big success. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innocan Pharma Corp. | - | - | - | - |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% | 57.846% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% | 93.736% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% | 51.788% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% | 61.648% |
According to Maxi_Scalibusa what are the pros and cons of Innocan Pharma Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Innocan Pharma Corp. diskutieren
In the thread Trading Innocan Pharma Corp.
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten